期刊文献+

甲型H1N1流感中医治疗疗效分析 被引量:14

Study on therapeutic effects of TCM on swine-origin influenza A(H1N1) virus patients
原文传递
导出
摘要 目的:分析中医治疗甲型H1N1流感疗效。方法:采用随机、开放性、对照的临床试验设计,对符合入选条件的48例确诊的甲型H1N1流感患者随机分为3组,其中单纯中药组14例,单纯奥司他韦组19例,奥司他韦配合中药组15例,统计3组病例的总病程、发热天数、咳嗽缓解时间、其他流感样症状(除咳嗽外)、甲型H1N1流感病毒RNA阳性持续时间。结果:对于无合并症的甲型H1N1流感患者,在发病48-72h内,在总的病程、除咳嗽外的其他流感症状缓解时间、流感病毒时间转阴上3组无统计学差异,使用中药组在缓解咳嗽这一症状上疗效较佳;使用奥司他韦组对缓解发热疗效较佳。结论:对于无并发症的甲型H1N1流感,中药治疗疗效显著,在总病程、流感病毒转阴时间、除咳嗽外的其他流感症状缓解时间与使用奥司他韦组治疗无差异。 Objective:To investigate the therapeutic effect of TCM on swine-origin influenza A(H1N1).Methods:A randomized,open,controlled clinical trial was designed,48 patients were divided into three groups:oseltamiver group(19 cases),TCM treatment group(14 cases),oseltamiver and TCM treatment group(15 cases).Results:There was no difference in the total course of disease,the time of flu-symptoms(except cough) and A/H1N1 virus disappeared among three groups(p0.05);The symptom remission time of cough in TCM treatment group was significantly shorter than that in oseltamiver group;The symptom remission time of fever in oseltamiver group was significantly shorter than that in TCM treatment group.Conclusion:TCM had good effect on swine-origin influenza A(H1N1) without complications.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2010年第5期780-782,共3页 China Journal of Traditional Chinese Medicine and Pharmacy
关键词 甲型H1N1流感 中医治疗 疗效 Swine-origin-Influenza-A(H1N1) TCM treatment Therapeutic effect
  • 相关文献

参考文献9

  • 1中华医学会呼吸病学分会.流行性感冒临床诊断和治疗治疗(2004年修订稿)[J].中华结核和呼吸杂志,2005,28(2):5-5.
  • 2中国疾病预防控制中心.甲型H1N1流感诊疗方案(2009年试行版第一版).2009年5月10日.
  • 3中国疾病预防控制中心.甲型H1N1流感确诊病例出院标准(试行).2009年5月18日.
  • 4WHO.Viral gene sequences to assist update diagnostics for swine influenza A(H1N1),April 25, 2009.
  • 5CDC.Interim Guidance on Antiviral Recommendations for Patients with Novel Influenza A (H1N1) Virus Infection and Their Close Contacts.May 6,2009.
  • 6Human infection with new influenza A(H1N1) virus:Mexico,update,March-May 2009.Wkly Epidemiol Rec,2009,84(23):213-9.
  • 7CDC.Swine-origin influenza A(H1N1) virus infections in a school- New York City,MMWR,2009,58:470-2.
  • 8钱铮.达菲能致幻.日本调查安全性.新华每日电讯,2007-03-26(007).
  • 9刘颂,王京燕.抗流感病毒药物的研究进展[J].国外医学(药学分册),2005,32(2):111-115. 被引量:33

二级参考文献18

  • 1Holmes EC. Virology. 1918 and all that [J]. Science,2034,303(5665) : 1787 - 1788.
  • 2Layne SP, Beugelsdijk TJ, Patel CK, et al. A global lab against influenza[J]. Science ,2001,293(5536) : 1729.
  • 3Wang J, Kim S, Kovacs F, et al. Structure of the transmembrane region of the M2 protein H^+ channel [ J ]. Protein Sci,2001,10( 11 ) :2241 - 2250.
  • 4Kelly ML, Cook JA, Brown-Augsburger P, et al. Demonstrafing the intrinsic ion channel activity of vitally encoded proteins[J]. FEBS Lett,2003,552(1) :61 - 67.
  • 5Salom D, Hill BR, lear JD, et al. pH-Dependent tetramerization and amantadine binding of the tmnsmembrane helix of M2 from the influenza A virus[J]. Biochemistry,2000,39(46) : 14160 - 14170.
  • 6Jefferson T, Deeks J, Demicheli V, et al. Amantadine and rimantadine for preventing and treating influenza A in adults[J]. Cochrane Database Syst Rev,2004,(3) :CD001169.
  • 7Saito R,Sakai T, Sato I, et al. Frequency of amantadine-resistant influenza A viruses during two seasons featuring cocirculation of H1N1 and H3N2[J]. J Clin Microbiol,2003,41(5) :2164 - 2165.
  • 8Astrahan P, Kass I, Cooper MA, et al. A novel method of resistance for influenza against a channel-blocking antiviral drug[J]. Proteins,2004,55(2) :251 - 257.
  • 9Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors[J]. Lancet, 2000, 355 (9206) : 827 -835.
  • 10Gubareva LV, Webster RG, Hayden FG. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants[ J ]. Antimicrobial Agents Chemother ,2001,45(12) :3403 - 3408.

共引文献34

同被引文献193

引证文献14

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部